# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Study shows no link between daily multivitamin use and lower risk of death in healthy adults. No difference in mortality from c...
Nestle's new Vital Pursuit brand targets individuals on weight-loss drugs without mentioning medications on packaging, addr...
Mizuho analyst John Baumgartner maintains Herbalife (NYSE:HLF) with a Neutral and raises the price target from $10 to $11.
DA Davidson analyst Linda Bolton Weiser maintains Herbalife (NYSE:HLF) with a Neutral and maintains $9.5 price target.